{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:56:22Z","timestamp":1776164182954,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,4,7]],"date-time":"2011-04-07T00:00:00Z","timestamp":1302134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s11940-011-0127-8","type":"journal-article","created":{"date-parts":[[2011,4,6]],"date-time":"2011-04-06T18:02:33Z","timestamp":1302112953000},"page":"371-379","source":"Crossref","is-referenced-by-count":36,"title":["Treatment of Depression in Patients with Epilepsy"],"prefix":"10.1007","volume":"13","author":[{"given":"Katherine H.","family":"Noe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dona E. C.","family":"Locke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph I.","family":"Sirven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,7]]},"reference":[{"key":"127_CR1","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1528-1167.2007.01222.x","volume":"48","author":"JF Tellez-Zenteno","year":"2007","unstructured":"Tellez-Zenteno JF, Patten SB, Jette N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population based analysis. Epilepsia. 2007;48:2336\u201344.","journal-title":"Epilepsia"},{"key":"127_CR2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00228-010-0861-y","volume":"66","author":"M Karouni","year":"2010","unstructured":"Karouni M, Arulthas S, Larsson PG, et al. Psychiatric comorbidity in patients with epilepsy: a population based study. Eur J Clin Pharmacol. 2010;66:1151\u201360.","journal-title":"Eur J Clin Pharmacol"},{"key":"127_CR3","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.0013-9580.2004.17504.x","volume":"45","author":"A Gaitatzis","year":"2004","unstructured":"Gaitatzis A, Carrol K, Majeed A, Sander W. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia. 2004;45:1613\u201322.","journal-title":"Epilepsia"},{"key":"127_CR4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.yebeh.2008.04.005","volume":"13","author":"JJ Barry","year":"2008","unstructured":"Barry JJ, Ettinger AB, Friel P, et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav. 2008;13:S1\u201329.","journal-title":"Epilepsy Behav"},{"key":"127_CR5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1474-4422(06)70415-X","volume":"5","author":"FC Gilliam","year":"2006","unstructured":"Gilliam FC, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicenter study. Lancet Neurol. 2006;5:399\u2013405.","journal-title":"Lancet Neurol"},{"key":"127_CR6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/bmj.b4108","volume":"339","author":"S Pilling","year":"2009","unstructured":"Pilling S, Anderson I, Goldberg D, et al. Depression in adults, including those with a chronic physical health problem: summary of NICE guidance. BMJ. 2009;339:1025\u20137.","journal-title":"BMJ"},{"key":"127_CR7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1006\/ebeh.2001.0271","volume":"2","author":"JW McAuley","year":"2001","unstructured":"McAuley JW, Long L, Heise J, Kirby T, et al. A prospective evaluation of the effects of a 12\u00a0week outpatient exercise program on clinical and behavioral outcomes in patients with epilepsy. Epilepsy Behav. 2001;2:592\u2013600.","journal-title":"Epilepsy Behav"},{"key":"127_CR8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1212\/01.WNL.0000073541.08356.47","volume":"61","author":"JI Sirven","year":"2003","unstructured":"Sirven JI, Drazkowski JF, Zimmerman RS, et al. Complementary\/alternative medicine for epilepsy in Arizona. Neurology. 2003;61:576\u20137.","journal-title":"Neurology"},{"key":"127_CR9","doi-asserted-by":"crossref","unstructured":"Linde K, Berner MM, Kriston L. St John\u2019s wort for major depression. Cochrane Database Syst Rev 2008;(4):CD000448.","DOI":"10.1002\/14651858.CD000448.pub3"},{"key":"127_CR10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1208\/s12248-009-9146-8","volume":"11","author":"F Borrelli","year":"2009","unstructured":"Borrelli F, Izzo AA. Herb-drug interactions with St. John\u2019s wort (Hypericum perforatum): an update on clinical observations. AAPS J. 2009;11:710\u201327.","journal-title":"AAPS J"},{"key":"127_CR11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1528-1157.1985.tb05676.x","volume":"26","author":"J Edeh","year":"1995","unstructured":"Edeh J, Toone BK. Antiepileptic therapy, folate deficiency, and psychiatric comorbidity: a general practice survey. Epilepsia. 1995;26:434\u201340.","journal-title":"Epilepsia"},{"key":"127_CR12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1176\/appi.neuropsych.15.1.64","volume":"15","author":"J Rosche","year":"2003","unstructured":"Rosche J, Uhlmann C, Froscher W. Low serum folate levels as a risk factor for depressive mood in patients with chronic epilepsy. J Neuropsychiatry Clin Neurosci. 2003;15:64\u20136.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"127_CR13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00002826-199504000-00008","volume":"18","author":"W Froscher","year":"1995","unstructured":"Froscher W, Maier V, Laage M, et al. Folate deficiency, anticonvulsant drugs, and psychiatric comorbidity. Clin Neuropharmacol. 1995;18:165\u201382.","journal-title":"Clin Neuropharmacol"},{"key":"127_CR14","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2165\/00003495-200868110-00003","volume":"68","author":"JM Miller","year":"2008","unstructured":"Miller JM, Kustra RP, Vuong A, Hammer AE, Messenheimer JA. Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs. Drugs. 2008;68:1493\u2013509.","journal-title":"Drugs"},{"key":"127_CR15","unstructured":"U.S. Department of Health and Human Services. Statistical review and evaluation: antiepileptic drugs and suicidality. Available at http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/08\/briefing\/2008-4372b1-01-FDA.pdf . Accessed March 23, 2011."},{"key":"127_CR16","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.2010.410","volume":"303","author":"E Patorno","year":"2010","unstructured":"Patorno E, Bohn RL, Wahl PM, et al. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA. 2010;303:1401\u20139.","journal-title":"JAMA"},{"key":"127_CR17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa0909801","volume":"363","author":"A Arana","year":"2010","unstructured":"Arana A, Wentworth CE, Ayuso-Mateos JL, Arellano FM. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med. 2010;363:542\u201351.","journal-title":"N Engl J Med"},{"key":"127_CR18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1212\/WNL.0b013e3181ea157e","volume":"75","author":"F Andersohn","year":"2010","unstructured":"Andersohn F, Schade R, Willich SN, Garbe E. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology. 2010;75:335\u201340.","journal-title":"Neurology"},{"key":"127_CR19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.yebeh.2003.08.009","volume":"4","author":"KU K\u00fchn","year":"2003","unstructured":"K\u00fchn KU, Quednow BB, Thiel M, et al. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav. 2003;4:674\u20139.","journal-title":"Epilepsy Behav"},{"key":"127_CR20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/ebeh.2000.0050","volume":"1","author":"AM Kanner","year":"2000","unstructured":"Kanner AM, Kozak AM, Frey M. The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav. 2000;1:100\u20135.","journal-title":"Epilepsy Behav"},{"key":"127_CR21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1006\/ebeh.2000.0123","volume":"1","author":"J Havorka","year":"2000","unstructured":"Havorka J, Herman E, Nemcova I. Treatment of interictal depression with citalopram in patients with epilepsy. Epilepsy Behav. 2000;1:444\u20137.","journal-title":"Epilepsy Behav"},{"key":"127_CR22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00002826-200405000-00009","volume":"27","author":"LM Specchio","year":"2004","unstructured":"Specchio LM, Iudice A, Specchio N, et al. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol. 2004;27:133\u20136.","journal-title":"Clin Neuropharmacol"},{"key":"127_CR23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.yebeh.2010.08.018","volume":"19","author":"S Cotterman-Hart","year":"2010","unstructured":"Cotterman-Hart S. Depression in epilepsy: Why aren\u2019t we treating? Epilepsy Behav. 2010;19:419\u201321.","journal-title":"Epilepsy Behav"},{"key":"127_CR24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","volume":"62","author":"K Alper","year":"2007","unstructured":"Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62:345\u201354.","journal-title":"Biol Psychiatry"},{"key":"127_CR25","first-page":"450","volume":"52","author":"JA Johnston","year":"1991","unstructured":"Johnston JA, Lineberry CG, Ascher JA, et al. A 102-center prospective study of seizure in association with bupropion. J Clin Psychiatry. 1991;52:450\u20136.","journal-title":"J Clin Psychiatry"},{"key":"127_CR26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1176\/appi.neuropsych.12.4.458","volume":"12","author":"A Gross","year":"2000","unstructured":"Gross A, Devinsky O, Westbrook LE, Wharton AH, Alper K. Psychotropic medication use in patients with epilepsy: effect on seizure frequency. J Neuropsychiatry Clin Neurosci. 2000;12:458\u201364.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"127_CR27","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0149-2918(08)80047-1","volume":"30","author":"E Spina","year":"2008","unstructured":"Spina E, Santoro V, D\u2019Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther. 2008;30:1206\u201327.","journal-title":"Clin Ther"},{"key":"127_CR28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.biopsych.2005.07.028","volume":"58","author":"MS George","year":"2005","unstructured":"George MS, Rush AJ, Marangell LB, et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment resistant depression. Biol Psychiatry. 2005;58:364\u201373.","journal-title":"Biol Psychiatry"},{"key":"127_CR29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopsych.2005.05.025","volume":"58","author":"JA Rush","year":"2005","unstructured":"Rush JA, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 2005;58:347\u201354.","journal-title":"Biol Psychiatry"},{"key":"127_CR30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/ebeh.2000.0046","volume":"1","author":"CL Harden","year":"2000","unstructured":"Harden CL, Pulver MC, Ravdin LD, et al. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav. 2000;1:93\u20139.","journal-title":"Epilepsy Behav"},{"key":"127_CR31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0193-953X(05)70198-2","volume":"23","author":"T Deckersbach","year":"2000","unstructured":"Deckersbach T, Gershuny BS, Otto MW. Cognitive behavioral therapy for depression. Applications and outcome. Psychiatr Clin North Am. 2000;23:795\u2013809.","journal-title":"Psychiatr Clin North Am"},{"key":"127_CR32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1037\/0022-006X.57.3.414","volume":"57","author":"KS Dobson","year":"1989","unstructured":"Dobson KS. A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol. 1989;57:414\u20139.","journal-title":"J Consult Clin Psychol"},{"key":"127_CR33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1037\/0033-2909.108.1.30","volume":"108","author":"LA Robinson","year":"1990","unstructured":"Robinson LA, Berman JS, Neimeyer RA. Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research. Psychol Bull. 1990;108:30\u201349.","journal-title":"Psychol Bull"},{"key":"127_CR34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0022-006X.58.4.482","volume":"58","author":"PD McLean","year":"1990","unstructured":"McLean PD, Hakstian AR. Relative endurance of unipolar depression treatment effects: longitudinal follow-up. J Consult Clin Psychol. 1990;58:482\u20138.","journal-title":"J Consult Clin Psychol"},{"key":"127_CR35","doi-asserted-by":"crossref","unstructured":"Ramaratnam S, Baker GA, Goldstein LH. Psychological treatments for epilepsy. Cochrane Database Syst Rev 2008;Issue 1:CD002029. DOI: 10.1002\/14651858.CD002029.pub3 .","DOI":"10.1002\/14651858.CD002029.pub3"},{"key":"127_CR36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yebeh.2010.06.003","volume":"19","author":"P Ciechanowski","year":"2010","unstructured":"Ciechanowski P, Chaytor N, Miller J, et al. PEARLS depression treatment for individuals with epilepsy: a randomized controlled trial. Epilepsy Behav. 2010;19:225\u201331.","journal-title":"Epilepsy Behav"},{"key":"127_CR37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0005-7967(02)00025-6","volume":"41","author":"LH Goldstein","year":"2003","unstructured":"Goldstein LH, McAlpine M, Deale A, et al. Cognitive behavior therapy with adults with intractable epilepsy and psychiatric co-morbidity: preliminary observations on changes in psychological state and seizure frequency. Behav Res Ther. 2003;41:447\u201360.","journal-title":"Behav Res Ther"},{"key":"127_CR38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.yebeh.2010.07.031","volume":"19","author":"NJ Thompson","year":"2010","unstructured":"Thompson NJ, Walker ER, Obolensky N, et al. Distance delivery of mindfulness based cognitive therapy for depression: Project UPLIFT. Epilepsy Behav. 2010;19:247\u201354.","journal-title":"Epilepsy Behav"},{"key":"127_CR39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yebeh.2010.10.028","volume":"20","author":"S Macrodimitris","year":"2011","unstructured":"Macrodimitris S, Weshler J, Hatfield M, et al. Group cognitive behavioral therapy for patients with epilepsy and comorbid anxiety and depression. Epilepsy Behav. 2011;20:83\u20138.","journal-title":"Epilepsy Behav"},{"key":"127_CR40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/15622970701320582","volume":"10","author":"KA Kucia","year":"2009","unstructured":"Kucia KA, Stepanczak R, Tredzbor B. Electroconvulsive therapy for major depression in an elderly person with epilepsy. World J Biol Psychiatry. 2009;10:78\u201380.","journal-title":"World J Biol Psychiatry"},{"key":"127_CR41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.yebeh.2006.06.013","volume":"9","author":"ME Lunde","year":"2006","unstructured":"Lunde ME, Lee EK, Rasmussen KG. Electroconvulsive therapy in patients with epilepsy. Epilepsy Behav. 2006;9:355\u20139.","journal-title":"Epilepsy Behav"},{"key":"127_CR42","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.biopsych.2007.01.018","volume":"62","author":"JP O\u2019Reardon","year":"2007","unstructured":"O\u2019Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208\u201316.","journal-title":"Biol Psychiatry"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-011-0127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-011-0127-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-011-0127-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T22:39:00Z","timestamp":1712356740000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-011-0127-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,7]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1007\/s11940-011-0127-8","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,7]]}}}